Shortly after Evofem picked up FDA approval for its contraceptive gel Phexxi back in 2020, the company touted the product as the "first contraceptive innovation in decades" and one that offered a new ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (“Aditxt”) (NASDAQ: ADTX), a company dedicated to discovering, developing, and deploying promising health innovations, announces this past Friday, ...

SAN DIEGO, March 26, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced that it has entered into a License and Supply Agreement (L&S Agreement) with ...

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products ...

After a year of financial challenges and struggling to stay alive, San Diego women’s health company Evofem Biosciences is being acquired for approximately $100 million. Evofem will become a wholly ...

The FDA has taken Evofem Biosciences to task for allegedly playing fast and loose with the facts, accusing the biotech of overstating the benefits of its contraceptive Phexxi in a digital patient ...

SAN DIEGO, April 14, 2025 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that members of its management team will present at the upcoming Emerging Growth Conference as follows ...